- Home
- ESPR vs NQP Comparison
ESPR vs NQP Comparison
Compare ESPR & NQP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- NQP
- Stock Information
- Founded
- ESPR 2008
- NQP 1990
- Country
- ESPR United States
- NQP United States
- Employees
- ESPR N/A
- NQP N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- NQP Trusts Except Educational Religious and Charitable
- Sector
- ESPR Health Care
- NQP Finance
- Exchange
- ESPR Nasdaq
- NQP Nasdaq
- Market Cap
- ESPR 399.0M
- NQP 438.1M
- IPO Year
- ESPR 2013
- NQP N/A
- Fundamental
- Price
- ESPR $2.30
- NQP $11.18
- Analyst Decision
- ESPR Buy
- NQP
- Analyst Count
- ESPR 5
- NQP 0
- Target Price
- ESPR $7.30
- NQP N/A
- AVG Volume (30 Days)
- ESPR 8.8M
- NQP 58.4K
- Earning Date
- ESPR 11-07-2024
- NQP 01-01-0001
- Dividend Yield
- ESPR N/A
- NQP 3.21%
- EPS Growth
- ESPR N/A
- NQP N/A
- EPS
- ESPR N/A
- NQP N/A
- Revenue
- ESPR $295,451,000.00
- NQP N/A
- Revenue This Year
- ESPR $186.90
- NQP N/A
- Revenue Next Year
- ESPR $31.10
- NQP N/A
- P/E Ratio
- ESPR N/A
- NQP N/A
- Revenue Growth
- ESPR 187.12
- NQP N/A
- 52 Week Low
- ESPR $1.58
- NQP $9.65
- 52 Week High
- ESPR $3.94
- NQP $11.89
- Technical
- Relative Strength Index (RSI)
- ESPR 44.79
- NQP 23.10
- Support Level
- ESPR $2.12
- NQP $12.00
- Resistance Level
- ESPR $2.54
- NQP $12.11
- Average True Range (ATR)
- ESPR 0.35
- NQP 0.14
- MACD
- ESPR -0.10
- NQP -0.09
- Stochastic Oscillator
- ESPR 21.90
- NQP 7.92
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About NQP Nuveen Pennsylvania Quality Municipal Income Fund
Nuveen Pennsylvania Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal and Pennsylvania income taxes and to enhance portfolio value relative to the municipal bond market by investing in municipal securities that are exempt from federal, Pennsylvania state and local income taxes. It invests a majority of its assets in securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.